Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Anatara Lifesciences Ltd

ANR.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Pharmaceuticals ·

Australia Micro Cap Analyst: N/A

Last Close

$0.01

▲ +0.00%

Market Cap $2.01M · Vol 5.82K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$2.01M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

0.00

Momentum

Beta

1.50

vs Market

52W High

$0.01

51.82% below

52W Low

$0.00

40.26% above

Volume

5.82K

Avg 44.97K

P/B

1.99

Price-to-book

ROE

N/A

Return on equity

Free Float

66.69%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Anatara Lifesciences Ltd (ANR.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ANR.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-10.00%

+0.00%

-18.18%

YTD

-35.71%

+28.57%

-67.13%

-93.82%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-1,286,190.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-138.64% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	1.99
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	315.95M

Technical Indicators

50-Day SMA	$0.01
200-Day SMA	$0.01
RSI (14)	0.00
Beta	1.50
52-Week High	$0.01
52-Week Low	$0.00

Volume Today	5.82K
Avg Daily Volume (30D)	44.97K
Relative Volume	0.13x
Volatility (10D)	49.98
Volatility (30D)	49.07
Free Float	66.69%

Analyst Consensus

N/A

Current Price $0.01

Mean Target N/A

52W Low$0.00 52W High$0.01

Current

Target

$0.00 $0.01

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG0077TH9J5

ISINAU000000ANR0

CountryAustralia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Anatara Lifesciences Ltd is an Australia-based life sciences company. The Company is engaged in developing evidence-based solutions for gastrointestinal diseases in humans and animals. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.